In Britain, news that the country had become the first to start administering a fully tested coronavirus vaccine was met with hope, excitement — and some trepidation.
Amid the optimism that normal life might soon resume, there is also concern. Has the vaccine been developed too fast? Is it safe? On today’s episode, we examine how Britons feel about the pros ... Show More
Today
A Week of Scandal, Reckoning and Resignations in Congress
This week, Congress was on the cusp of doing something that has never happened in U.S. history: forcibly removing four House members. Two of those members resigned. Michael Gold, who covers Congress, explains what unfolded on Capitol Hill, and what the events tell us about how wi ... Show More
26m 24s
Apr 15
Trump’s Risky Strategy to Blockade Iran’s Blockade
Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ... Show More
27m 18s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy.
Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s